Harbor Investment Advisory, LLC Neogenomics Inc Transaction History

Harbor Investment Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 14, 2023	BUY	$14.1 - $19.83 $3,849 - $5,413	273 Added 14.36%	2,174 $34,000
Q1 2023 Apr 21, 2023	BUY	$9.09 - $19.45 $2,527 - $5,407	278 Added 17.13%	1,901 $33,000
Q1 2022 Apr 20, 2022	BUY	$12.15 - $35.28 $5,989 - $17,393	493 Added 43.63%	1,623 $20,000
Q3 2021 Oct 12, 2021	BUY	$41.66 - $52.52 $47,075 - $59,347	1,130 New	1,130 $55,000
Q3 2020 Oct 23, 2020	SELL	$33.26 - $40.48 $731 - $890	-22 Closed	0 $0
Q2 2020 Jul 16, 2020	BUY	$24.21 - $31.02 $532 - $682	22 New	22 $1,000

291

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.76B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Harbor Investment Advisory, LLC with notifications on news.